Vicarious Surgical Inc.

07/27/2026 | Press release | Distributed by Public on 07/27/2026 14:10

Termination Notice (Form 15-12G)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 001-39384

Vicarious Surgical, Inc.

(Exact name of registrant as specified in its charter)

78 Fourth Avenue

Waltham, Massachusetts 02451

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)
Class A Common Stock
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)
Rule 12g-4(a)(2)
Rule 12h-3(b)(1)(i)
Rule 12h-3(b)(1)(ii)
Rule 15d-6
Rule 15d-22 (b)

Approximate number of holders of record as of the certification or notice date: 31

Pursuant to the requirements of the Securities Exchange Act of 1934, Vicarious Surgical, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Dated: July 21, 2026 By: /s/ Stephen From

Name:

Stephen From

Title: Chief Executive Officer
Vicarious Surgical Inc. published this content on July 27, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 27, 2026 at 20:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]